Specific Therapeutic Class Codes - M

HIC3 HIC3 Description
M0A BLOOD COMPONENTS
M0B PLASMA PROTEINS
M0C BLOOD FACTORS,MISCELLANEOUS
M0D PLASMA EXPANDERS
M0E ANTIHEMOPHILIC FACTORS
M0F FACTOR IX PREPARATIONS
M0G ANTIPORPHYRIA FACTORS
M0H FACTOR II PREPARATIONS
M0I FACTOR IX COMPLEX (PCC) PREPARATIONS
M0J FACTOR VII PREPARATIONS
M0K FACTOR X PREPARATIONS
M0L HUMAN MONOCLONAL ANTIBODY COMPLEMENT (C5) INHIBITOR
M0M PROTEIN C PREPARATIONS
M0N C1 ESTERASE INHIBITORS
M0R BLOOD ALBUMIN PREPARATIONS
M0S SYNTHETIC BLOOD PREPARATIONS
M0U RED BLOOD CELL VOLUME (AND RELATED) DIAGNOSTICS
M3A OCCULT BLOOD TESTS
M3B BLOOD UREA NITROGEN TESTS
M4A BLOOD SUGAR DIAGNOSTICS
M4B IV FAT EMULSIONS
M4C LIPOTROPICS (CONTINUED 2)
M4D ANTIHYPERLIPIDEMIC - HMG COA REDUCTASE INHIBITORS
M4E LIPOTROPICS
M4F LIPOTROPICS (CONTINUED 1)
M4G HYPERGLYCEMICS
M4H AGENTS THAT AFFECT CELLULAR LIPIDS
M4I ANTIHYPERLIP - HMG-COA AND CALCIUM CHANNEL BLOCKER CB
M4J ANTIHYPERLIPIDEMIC - HMG COA AND PLATELET INHIBITOR COMBINATION
M4K ANTIHYPERLIPIDEMIC - HMG COA REDUCTASE INHIBITOR (COMBINATION TO DBD)
M4L ANTIHYPERLIPIDEMIC - HMG COA REDUCTASE INHIBITOR AND NIACIN
M4M ANTIHYPERLIPIDEMIC - HMG COA REDUCTASE INHIBITOR AND CHOLEST.AB.INHIB
M4N ANTIHYPERLIPIDEMIC-NICOT AC DER AND DP1 REC ANT COMBINATION
M4O ORAL LIPID SUPPLEMENTS
M9A TOPICAL HEMOSTATICS
M9D ANTIFIBRINOLYTIC AGENTS
M9E THROMBIN INHIBITORS,SEL.,DIRECT,&REV.-HIRUDIN TYPE
M9F THROMBOLYTIC ENZYMES
M9J CITRATES AS ANTICOAGULANTS
M9K HEPARIN AND RELATED PREPARATIONS
M9L ANTICOAGULANTS,COUMARIN TYPE
M9M ORAL ANTICOAGULANTS,INDANDIONE TYPE
M9P PLATELET AGGREGATION INHIBITORS
M9R COAGULANTS
M9S HEMORRHEOLOGIC AGENTS
M9T THROMBIN INHIBITORS, SELECTIVE, DIRECT, & REVERSIBLE
M9U THROMBOLYTIC - NUCLEOTIDE TYPE
M9V DIRECT FACTOR XA INHIBITORS

 

Return to Drug Specific Therapeutic Class Codes and Descriptions